Willingness to participate in HIV vaccine trials: the impact of trial attributes.
about
The Community Liaison Program: a health education pilot program to increase minority awareness of HIV and acceptance of HIV vaccine trialsUsing social networks to recruit an HIV vaccine preparedness cohortKnowledge and attitudes towards HIV vaccines among Soweto adolescents.Endorsement of compulsory HIV vaccination policy among populations at high risk of HIV exposure (LA VOICES).Beliefs about participating in research among a sample of minority persons living with HIV/AIDS in New York City.HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations."Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.Conceptual framework for behavioral and social science in HIV vaccine clinical research.Engaging members of African American and Latino communities in preventive HIV vaccine trials.Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City.Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infection.Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling.Sources of racial/ethnic differences in awareness of HIV vaccine trials.
P2860
Q24597056-9B5D165F-71A9-4AF9-A5A5-5E809382A390Q30227795-8E59492B-FF11-4B0A-915D-4777B833BF56Q30847508-812280B9-84D5-4BB1-9EC7-A23A81D75BD2Q33638974-F458C622-F1AC-4363-AB67-4E2187A59EE8Q34117161-D4DA980A-02F5-472B-AB83-59345F9C3179Q34313611-BE605B8E-B420-4FC4-A7DA-D6402A1EF3AFQ34989216-1293E79D-5C10-48A6-8DB4-B1D8884D8FB7Q35219438-940A9099-A2C4-4157-BFF4-9F0261BF90BEQ35301155-DFD8C3F2-E6E1-4CB8-8CD7-6C451D388106Q35736408-35BCEEEA-EBD6-43A1-BC10-6FC7FDC2C714Q36853358-85E1B0F7-4B02-436E-8395-FDBC9AB58ADFQ37409508-D22E300A-7857-4D62-B630-AE55A7619465Q39919006-1248BA3B-CA1A-43C7-A594-2F6345A3C9DBQ52323543-858FED34-118C-462C-BD34-D9B1AB3998B8Q53840337-94D6730C-06D3-4F72-9F79-70B9EA253FCE
P2860
Willingness to participate in HIV vaccine trials: the impact of trial attributes.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Willingness to participate in HIV vaccine trials: the impact of trial attributes.
@ast
Willingness to participate in HIV vaccine trials: the impact of trial attributes.
@en
type
label
Willingness to participate in HIV vaccine trials: the impact of trial attributes.
@ast
Willingness to participate in HIV vaccine trials: the impact of trial attributes.
@en
prefLabel
Willingness to participate in HIV vaccine trials: the impact of trial attributes.
@ast
Willingness to participate in HIV vaccine trials: the impact of trial attributes.
@en
P2093
P2860
P1433
P1476
Willingness to participate in HIV vaccine trials: the impact of trial attributes.
@en
P2093
Danielle Seiden
Ellen Rudy
Lisa Kakinami
Naihua Duan
Sung-Jae Lee
William Cunningham
P2860
P304
P356
10.1016/J.YPMED.2006.12.007
P407
P577
2006-12-24T00:00:00Z